Progress in allogeneic hematopoietic stem cell transplantation in treatment of hematological malignancies / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 65-67,82, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-605848
ABSTRACT
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a curable method for hematological malignancies.Nearly all transplant candidates have donor with the successful application of haploidentical SCT.This article summarized some reports on donor selection,prophylaxis and treatment of graft-versus-host disease,and graft failure in the 58th American Society of Hematology Annual Meeting to present the progress of allo-HSCT in treating hematological malignancies.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Leukemia & Lymphoma
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS